Bioresorbable Vascular Scaffolds in the Clinical Setting
Bioresorbable Vascular Scaffolds in the Clinical Setting
BRS is a relatively new technology that was introduced to address the limitations of the traditional metallic stents. They have introduced a unique potential in the treatment of coronary lesions as they provide temporary vessel scaffolding, before disappearing, thereby allowing for the restoration of the vessel wall physiology and vasomotion. Evidence from the validation of the second-generation BRSs indicates that they have overcome the drawbacks of the first-generation devices (e.g., rapid bioresorption and device shrinkage) and are able to compete with the metallic stents in terms of safety and efficacy. Evidence from studies that are already underway may show whether the BRS will become the standard interventional treatment of coronary artery disease.
Conclusion & Future Perspective
BRS is a relatively new technology that was introduced to address the limitations of the traditional metallic stents. They have introduced a unique potential in the treatment of coronary lesions as they provide temporary vessel scaffolding, before disappearing, thereby allowing for the restoration of the vessel wall physiology and vasomotion. Evidence from the validation of the second-generation BRSs indicates that they have overcome the drawbacks of the first-generation devices (e.g., rapid bioresorption and device shrinkage) and are able to compete with the metallic stents in terms of safety and efficacy. Evidence from studies that are already underway may show whether the BRS will become the standard interventional treatment of coronary artery disease.
